Walgreens has slipped behind CVS because it’s smaller than CVS, giving it less scale to negotiate prices with insurers and ...
The struggling pharmacy chain has already provided some clues to which parts of the business a new owner may want off the ...
Private equity-linked healthcare transactions are poised to rebound as interest rates cool and a new presidential administration takes over.
Here are five recent private equity deals, finalized or rumored, that ASCs are eyeing: ...
THE future of Boots has been plunged into uncertainty while a buyout fund negotiates with its US owner. Pharmacy giant ...
In a deal that could value the chain at $10 billion, the discussions mark a potential shift for the 175-year-old brand ...
Looking to 2025, Peluchiwski’s group forecasts that industrials dealflow will increase 20-25 percent in the year ahead, as ...
In contrast, Boots has recently reported an significant uptick in its financial performance, benefiting hugely from its growing online and makeup sales. The high street chemist, which was founded in ...
The nationals report on Boots' potential sale overnight, a cyber attack impacting Krispy Kreme's online orders and the ...
Plus: A mystery disease is currently circulating in Congo, how patients are using AI to fight claim denials and raw milk may ...